½ÃÀ庸°í¼­
»óǰÄÚµå
1574003

¼¼°èÀÇ ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ¼ºº°º°, ¿¬·ÉÃþº°, ÃÖÁ¾ »ç¿ëÀÚº°, ¿ëµµº°, À¯Åë ä³Îº° - ¿¹Ãø(2025-2030³â)

Continence Care Market by Product Type (External Catheters, Indwelling Catheters, Intermittent Catheters), Usage (Disposable, Reusable), Gender, Age Group, End User, Application, Distribution Channel - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 191 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÄÁƼ³Í½º ÄÉ¾î ½ÃÀåÀº 2023³â¿¡ 23¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 25¾ï 5,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 7.53%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 39¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå¿¡´Â ¼¼°è ¼ö¹é¸¸ ¸íÀÌ ¾Î°í ÀÖ´Â ¿ä½Ç±Ý ¹× Æí½Ç±ÝÀ» °ü¸®Çϱâ À§ÇÑ Á¦Ç°°ú ¼­ºñ½º°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ Çʿ伺Àº Àα¸ °í·ÉÈ­, ¶óÀÌÇÁ ½ºÅ¸ÀÏ ¿äÀÎÀ¸·Î ÀÎÇÑ Ã»¼Ò³â ½Ç±Ý À¯º´·ü Áõ°¡, ¼ö¼ú, ´ç´¢º´ ¹× ºñ¸¸°ú °°Àº º´¸®ÇÐÀ» ¹è°æÀ¸·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿ëµµ¿¡´Â ¼ºÀÎ¿ë ±âÀú±Í, Ä«Å×ÅÍ, ¿ä±â µîÀÇ Á¦Ç°°ú ´õ ³ªÀº Áúº´ ¸ð´ÏÅ͸µ ¹× °ü¸®¸¦ À§ÇÑ ¿þ¾î·¯ºí ¼¾¼­ ¹× IoT Áö¿ø ÀåÄ¡¿Í °°Àº ÷´Ü ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÃÖÁ¾ ¿ëµµ´Â ÁÖ·Î º´¿ø, ÀçÅà °£º´ ȯ°æ, Àå±â °£º´ ½Ã¼³ÀÔ´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ½Ç±Ý °ü¸®¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í ±â¼úÀÇ Áøº¸, À¯¸®ÇÑ »óȯ Á¤Ã¥ µîÀÌ ÀÖ½À´Ï´Ù. ģȯ°æ Á¦Ç°°ú ½º¸¶Æ® ±â¼ú °³¹ßÀº ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ½ÃÀå ±â¾÷Àº »ýºÐÇØ¼º ½Ç±Ý ÆÐµå ¹× AI žÀç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇÏ´Â °ÍÀÌ ÁÁ½À´Ï´Ù. ¶ÇÇÑ Á¦Ç° Å×½ºÆ® ¹× ÀÓ»ó °ËÁõÀ» À§ÇÑ ÀÇ·á ½Ã¼³°úÀÇ Á¦ÈÞ´Â ½ÃÀå ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇѰè·Î´Â ¼±ÁøÀûÀÎ ÄÁƼ³Í½º Äɾî Á¦Ç°ÀÇ °í¾×ÀÇ ºñ¿ë, ½Ç±Ý¿¡ °ü·ÃµÈ ½ºÆ¼±×¸¶(³«ÀÎ)°¡ ÀÖÀ¸¸ç, ¼ÒºñÀÚÀÇ Ã¤¿ëÀ» ¹æÇØÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±ÔÁ¦ ¹®Á¦¿Í ¾ö°ÝÇÑ ÄÄÇöóÀ̾𽺠±âÁØ ¿ä±¸ »çÇ×µµ Á¦Çѵ˴ϴÙ. ½ÃÀå ¼ºÀåÀº ºê·£µå ¹«°á¼º°ú °í°´ ½Å·Ú¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â À§Á¶Ç°ÀÇ Á¸Àç·Î ÀÎÇØ ´õ¿í ¾î·Á¿öÁý´Ï´Ù. Çõ½ÅÀº ÇÕ¸®ÀûÀÎ °¡°Ý, Æí¾ÈÇÔ, ½ÅÁßÇÔ, »ç¿ëÀÚ ÀÚ¸³¼º °­È­¿¡ ÁßÁ¡À» µÎ¾î¾ß ÇÕ´Ï´Ù. ±â¾÷Àº ½ºÆ¼±×¸¶¸¦ ¿ÏÈ­Çϰí ÀÌÇØ¸¦ ÃËÁøÇϱâ À§ÇØ Àú·ÅÇÑ Á¦Ç° ¶óÀΰú ±³À° Ä·ÆäÀÎÀ» Á¶Á¤ÇÔÀ¸·Î½á ÃæÁ·µÇÁö ¾ÊÀº ¿ä±¸¸¦ °¡Áø Áö¿ªÀ» °³Ã´ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ¿ªÇÐÀÇ ÀλçÀÌÆ®·ÎºÎÅÍ Çõ½ÅÀûÀÎ Á¦Ç°ÀÇ Á¦°ø°ú Àü·«Àû Á¦ÈÞ¿¡ ÀÇÇÑ Â÷º°È­ÀÇ ±âȸ¸¦ °¡Áö´Â Áß°£ Á¤µµÀÇ °æÀï ȯ°æÀÌ ¹àÇôÁ³½À´Ï´Ù. Áö¼ÓÀûÀÎ ¼ºÀåÀ» ´Þ¼ºÇϱâ À§ÇØ, ¾÷°è´Â ±â´ÉÀû ¿ä±¸¿Í Á¤¼­Àû ¿ä±¸ ¸ðµÎ¿¡ ´ëÀÀÇÏ´Â ¼ÒºñÀÚ Áß½ÉÀÇ ¼Ö·ç¼ÇÀ» ¿ì¼±½ÃÇØ¾ß Çϸç, »ýüÀûÇÕ¼º ¼ÒÀç¿Í »ç¿ëÇϱ⠽¬¿î µðÀÚÀο¡ °üÇÑ Á¶»çÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù. ¿ø°Ý ÀÇ·á ÅëÇÕÀÇ »õ·Î¿î µ¿ÇâÀº ¿ø°Ý ÄÁƼ³Í½º ÄÉ¾î °ü¸®¿¡ ´ëÇÑ °æ·Îµµ Á¦½ÃÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Ãß°¡ ޱ¸ÀÇ ÇÙ½ÉÀÌ µÉ ¼öÀÖ´Â ºÐ¾ßÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023³â) 23¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 25¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 39¾ï 8,000¸¸ ´Þ·¯
CAGR(%) 7.53%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÄÁƼ³Í½º ÄÉ¾î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÄÁƼ³Í½º ÄÉ¾î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½Ç±Ý ¹®Á¦·Î À̾îÁö´Â ´ç´¢º´À̳ª ºñ¸¸ µîÀÇ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡
    • ȯÀÚÀÇ QOL Çâ»óÀ» ¸ñÀûÀ¸·Î ÇÑ Ã·´Ü ÄÁƼ³Í½º Äɾî Á¦Ç°ÀÇ Ã¤¿ë È®´ë
    • Á¤ºÎ³ª ´Üü¿¡ ÀÇÇÑ ÄÁƼ³Í½º Äɾ °üÇÑ °è¹ß Ä·ÆäÀÎÀ̳ª ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡
    • ÄèÀû¼º°ú À¯È¿¼ºÀ» ³ôÀÌ´Â ÄÁƼ³Í½º Äɾî Á¦Ç°ÀÇ ±â¼úÀû Áøº¸
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °ø±Þ¸ÁÀÇ È¥¶õ°ú ¿øÀç·á ºÎÁ·ÀÌ ÄÁƼ³Í½º Äɾî Á¦Ç° »ý»ê¿¡ ¿µÇâ
  • ½ÃÀå ±âȸ
    • ȯ°æ ÀǽÄÀÌ ³ôÀº ¼ÒºñÀÚ¸¦ Ÿ°ÙÀ¸·Î ÇÑ, ȯ°æ ģȭÀûÀÎ »ýºÐÇØ¼º ÄÜÆ¼³Ù½º Äɾî Á¦Ç° µµÀÔ
    • ÀÇ·á Á¦°øÀÚ¿ÍÀÇ Á¦ÈÞ¿¡ ÀÇÇÑ ÄÁƼ³Í½º ÄÉ¾î ¼Ö·ç¼ÇÀÇ ÅëÇÕ°ú ȯÀÚ °á°úÀÇ °³¼±
    • ¿©¼º°ú ³ëÀΰú °°Àº ƯÁ¤ ÃþÀÇ ½Ç±Ý¿¡ ´ëÀÀÇÏ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» À§ÇÑ ¿¬±¸°³¹ß ÅõÀÚ
  • ½ÃÀåÀÇ °úÁ¦
    • ÄÁƼ³Í½º ÄɾîÀÇ ¼±Åÿ¡ ´ëÇÑ ÇコÄɾî Àü¹®°¡³ª ȯÀÚÀÇ ÀÎ½Ä ¹× ±³À°ÀÌ ÇÑÁ¤Àû

Porter's Five Forces : ÄÁƼ³Í½º ÄÉ¾î ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ÄÜÆ¼³Ù½º ÄÉ¾î ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÄÁƼ³Í½º ÄÉ¾î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÄÁƼ³Í½º ÄÉ¾î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æ ±×¸®±â

ÄÁƼ³Í½º ÄÉ¾î ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ´ç´¢º´À̳ª ºñ¸¸ µîÀÇ ¸¸¼º Áúȯ Áõ°¡°¡ ½Ç±Ý ¹®Á¦·Î ¿¬°á
      • ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â °í±Þ ÄÁƼ³Í½º Äɾî Á¦Ç°ÀÇ Ã¤¿ë Áõ°¡
      • Á¤ºÎ³ª Á¶Á÷¿¡ ÀÇÇÑ ÄÁƼ³Í½º Äɾ °üÇÑ °è¹ß Ä·ÆäÀÎÀ̳ª ´ëó °íÁ¶
      • »ç¿ëÀÚÀÇ ÄèÀû¼º°ú À¯È¿¼ºÀ» ³ôÀÌ´Â ÄÁƼ³Í½º Äɾî Á¦Ç°ÀÇ ±â¼úÀû Áøº¸
    • ¾ïÁ¦¿äÀÎ
      • °ø±Þ¸ÁÀÇ È¥¶õ ¹× ¿øÀç·á ºÎÁ·ÀÌ ÄÁƼ³Í½º Äɾî Á¦Ç°ÀÇ »ý»ê¿¡ ¿µÇâ
    • ±âȸ
      • ȯ°æ ÀǽÄÀÌ ³ôÀº ¼ÒºñÀÚ¸¦ Ÿ°ÙÀ¸·Î ÇÑ È¯°æ ģȭÀûÀÎ »ýºÐÇØ¼º ÄÜÆ¼³Ù½º Äɾî Á¦Ç° µµÀÔ
      • ÀÇ·á Á¦°øÀÚ¿Í Á¦ÈÞÇØ ÅëÇÕµÈ ÄÁƼ³Í½º ÄÉ¾î ¼Ö·ç¼ÇÀ» Á¦°øÇØ, ȯÀÚÀÇ °á°ú °³¼±
      • ¿©¼º ¹× ³ëÀΰú °°Àº ƯÁ¤ Àα¸ÃþÀÇ ½Ç±Ý¿¡ ´ëóÇÏ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ ¿¬±¸ °³¹ß ÅõÀÚ
    • °úÁ¦
      • ÇコÄɾî Á¾»çÀÚ¿Í È¯ÀÚ »çÀÌ¿¡ ÄÁƼ³Í½º ÄÉ¾î ¿É¼Ç¿¡ ´ëÇÑ Àνİú ±³À°ÀÇ ÇÑÁ¤
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¿ÜºÎ Ä«Å×ÅÍ
    • ¿©¼º¿ë ¿ÜºÎ Ä«Å×ÅÍ
    • ³²¼º¿ë ¿ÜºÎ Ä«Å×ÅÍ
  • À¯Ä¡ Ä«Å×ÅÍ
    • Æú¸® Ä«Å×ÅÍ
    • Ä¡°ñ»ó Ä«Å×ÅÍ
  • °£Çæ Ä«Å×ÅÍ
    • ÄÚÆÃ °£Çæ Ä«Å×ÅÍ
    • ¹«ÄÚÆÃ °£Çæ Ä«Å×ÅÍ

Á¦7Àå ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå : ¿ëµµº°

  • ÀÏȸ¿ë
  • Àç»ç¿ë °¡´É

Á¦8Àå ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå : ¼ºº°

  • ¿©¼º
  • ³²ÀÚ

Á¦9Àå ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå : ¿¬·ÉÃþº°

  • ¼ºÀοë
  • ³ë³âº´
  • ¼Ò¾Æ°ú

Á¦10Àå ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Ŭ¸®´Ð
    • Àü¹® Ŭ¸®´Ð
    • ºñ´¢±â°ú Ŭ¸®´Ð
  • ȨÄɾî
  • º´¿ø
    • »ç¸³º´¿ø
    • °ø¸³º´¿ø
  • Àå±â °£º´ ½Ã¼³

Á¦11Àå ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå : ¿ëµµº°

  • ¾ç¼º Àü¸³¼± ºñ´ëÁõ
  • ±âŸ ºñ´¢±â Áúȯ
  • ô¼ö ¼Õ»ó
  • ¿ä½Ç±Ý
    • ±â´É¼º ½Ç±Ý
    • Èê·¯³ÑÄ¡´Â ½Ç±Ý
    • º¹¾Ð¼º ¿ä½Ç±Ý
    • Àý¹Ú¼º ¿ä½Ç±Ý

Á¦12Àå ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå : À¯Åë ä³Îº°

  • º´¿ø ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹
  • ¼Ò¸Å ¾à±¹

Á¦13Àå ¾Æ¸Þ¸®Ä«ÀÇ ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦14Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦15Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÄÁƼ³Í½º ÄÉ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È
AJY 24.10.28

The Continence Care Market was valued at USD 2.39 billion in 2023, expected to reach USD 2.55 billion in 2024, and is projected to grow at a CAGR of 7.53%, to USD 3.98 billion by 2030.

The continence care market encompasses products and services designed to manage urinary and fecal incontinence, a condition affecting millions worldwide. The necessity for these solutions is driven by the aging population, rising prevalence of incontinence among younger demographics due to lifestyle factors, surgeries, or medical conditions such as diabetes and obesity. Application includes products like adult diapers, catheters, urinals, and advanced technologies such as wearable sensors and IoT-enabled devices for better disease monitoring and management. End-use primarily focuses on hospitals, home care settings, and long-term care facilities. Key growth factors include increasing awareness about incontinence management, technological advancements, and favorable reimbursement policies. The development of eco-friendly products and smart technologies provides potential opportunities for growth. Market players are advised to invest in research and development for innovative solutions like biodegradable incontinence pads and AI-powered monitoring systems. Additionally, partnerships with healthcare facilities for product testing and gaining clinical validation can fortify market positions. Limitations include high costs of advanced continence care products and stigma associated with incontinence, which may hinder consumer adoption. Regulatory challenges and the requirement for rigorous compliance standards also pose constraints. Market growth is further challenged by the presence of counterfeit products impacting brand integrity and customer trust. Innovations should focus on affordability, comfort, discretion, and enhancing user independence. Companies can explore underrepresented regions with unmet needs by tailoring affordable product lines and educational campaigns to reduce stigma and promote understanding. Insights into market dynamics reveal a moderately competitive environment with opportunities for differentiation through innovative product offerings and strategic alliances. To achieve sustained growth, the industry must prioritize consumer-centric solutions addressing both functional and emotional needs, emphasizing the importance of research into biocompatible materials and user-friendly designs. Emerging trends in telehealth integration also offer pathways for remote continence care management, which could be a key area for further exploration.

KEY MARKET STATISTICS
Base Year [2023] USD 2.39 billion
Estimated Year [2024] USD 2.55 billion
Forecast Year [2030] USD 3.98 billion
CAGR (%) 7.53%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continence Care Market

The Continence Care Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic conditions such as diabetes and obesity leading to incontinence issues
    • Growing adoption of advanced continence care products for improving patient quality of life
    • Rising awareness campaigns and initiatives by governments and organizations about continence care
    • Technological advancements in continence care products enhancing user comfort and efficacy
  • Market Restraints
    • Supply chain disruptions and raw material shortages affect the production of continence care products
  • Market Opportunities
    • Introduction of eco-friendly and biodegradable continence care products targeting environmentally conscious consumers
    • Partnering with healthcare providers for integrated continence care solutions and better patient outcomes
    • Investment in R&D for innovative solutions addressing incontinence in specific demographics such as women and elderly
  • Market Challenges
    • Limited awareness and education about continence care options among healthcare professionals and patients

Porter's Five Forces: A Strategic Tool for Navigating the Continence Care Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continence Care Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continence Care Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continence Care Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continence Care Market

A detailed market share analysis in the Continence Care Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continence Care Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continence Care Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Continence Care Market

A strategic analysis of the Continence Care Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Continence Care Market, highlighting leading vendors and their innovative profiles. These include Attends Healthcare Products Inc., B. Braun Melsungen AG, Coloplast, ConvaTec Group Plc, Domtar Corporation, Drylock Technologies, Dynarex Corporation, Essity AB, Hollister Incorporated, Kimberly-Clark Corporation, Medtronic plc, Ontex Group NV, PAUL HARTMANN AG, Principle Business Enterprises Inc., Procter & Gamble Co., SCA (Svenska Cellulosa Aktiebolaget), TENA (a brand of Essity), Tranquility Products, TZMO SA, and Urinary Systems Inc..

Market Segmentation & Coverage

This research report categorizes the Continence Care Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across External Catheters, Indwelling Catheters, and Intermittent Catheters. The External Catheters is further studied across Female External Catheters and Male External Catheters. The Indwelling Catheters is further studied across Foley Catheters and Suprapubic Catheters. The Intermittent Catheters is further studied across Coated Intermittent Catheters and Uncoated Intermittent Catheters.
  • Based on Usage, market is studied across Disposable and Reusable.
  • Based on Gender, market is studied across Female and Male.
  • Based on Age Group, market is studied across Adult, Geriatric, and Pediatric.
  • Based on End User, market is studied across Clinics, Homecare, Hospitals, and Long-Term Care Facilities. The Clinics is further studied across Specialty Clinics and Urology Clinics. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Application, market is studied across Benign Prostate Hyperplasia, Other Urological Disorders, Spinal Cord Injuries, and Urinary Incontinence. The Urinary Incontinence is further studied across Functional Incontinence, Overflow Incontinence, Stress Incontinence, and Urge Incontinence.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic conditions such as diabetes and obesity leading to incontinence issues
      • 5.1.1.2. Growing adoption of advanced continence care products for improving patient quality of life
      • 5.1.1.3. Rising awareness campaigns and initiatives by governments and organizations about continence care
      • 5.1.1.4. Technological advancements in continence care products enhancing user comfort and efficacy
    • 5.1.2. Restraints
      • 5.1.2.1. Supply chain disruptions and raw material shortages affect the production of continence care products
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of eco-friendly and biodegradable continence care products targeting environmentally conscious consumers
      • 5.1.3.2. Partnering with healthcare providers for integrated continence care solutions and better patient outcomes
      • 5.1.3.3. Investment in R&D for innovative solutions addressing incontinence in specific demographics such as women and elderly
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and education about continence care options among healthcare professionals and patients
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Continence Care Market, by Product Type

  • 6.1. Introduction
  • 6.2. External Catheters
    • 6.2.1. Female External Catheters
    • 6.2.2. Male External Catheters
  • 6.3. Indwelling Catheters
    • 6.3.1. Foley Catheters
    • 6.3.2. Suprapubic Catheters
  • 6.4. Intermittent Catheters
    • 6.4.1. Coated Intermittent Catheters
    • 6.4.2. Uncoated Intermittent Catheters

7. Continence Care Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Continence Care Market, by Gender

  • 8.1. Introduction
  • 8.2. Female
  • 8.3. Male

9. Continence Care Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Geriatric
  • 9.4. Pediatric

10. Continence Care Market, by End User

  • 10.1. Introduction
  • 10.2. Clinics
    • 10.2.1. Specialty Clinics
    • 10.2.2. Urology Clinics
  • 10.3. Homecare
  • 10.4. Hospitals
    • 10.4.1. Private Hospitals
    • 10.4.2. Public Hospitals
  • 10.5. Long-Term Care Facilities

11. Continence Care Market, by Application

  • 11.1. Introduction
  • 11.2. Benign Prostate Hyperplasia
  • 11.3. Other Urological Disorders
  • 11.4. Spinal Cord Injuries
  • 11.5. Urinary Incontinence
    • 11.5.1. Functional Incontinence
    • 11.5.2. Overflow Incontinence
    • 11.5.3. Stress Incontinence
    • 11.5.4. Urge Incontinence

12. Continence Care Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Hospital Pharmacies
  • 12.3. Online Pharmacies
  • 12.4. Retail Pharmacies

13. Americas Continence Care Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Continence Care Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Continence Care Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Attends Healthcare Products Inc.
  • 2. B. Braun Melsungen AG
  • 3. Coloplast
  • 4. ConvaTec Group Plc
  • 5. Domtar Corporation
  • 6. Drylock Technologies
  • 7. Dynarex Corporation
  • 8. Essity AB
  • 9. Hollister Incorporated
  • 10. Kimberly-Clark Corporation
  • 11. Medtronic plc
  • 12. Ontex Group NV
  • 13. PAUL HARTMANN AG
  • 14. Principle Business Enterprises Inc.
  • 15. Procter & Gamble Co.
  • 16. SCA (Svenska Cellulosa Aktiebolaget)
  • 17. TENA (a brand of Essity)
  • 18. Tranquility Products
  • 19. TZMO SA
  • 20. Urinary Systems Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦